Head-to-head · WeighScore
KERNX Health vs Piper
The verdict
Piper takes it — 81.9/100 to 71.8/100.
Piper grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Mid-value both-molecule pricing ($135/$199), nationwide, though not verified.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | KERNX Health | Piper |
|---|---|---|
| WeighScore | 71.8/100 | 81.9/100 |
| Grade | C | B− |
| Scorecard rank | #101 | #32 |
| Semaglutide | $129/mo (compounded, plus a one-time consultation fee) | $135/mo |
| Tirzepatide | $229/mo (compounded, plus a one-time consultation fee) | $199/mo |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #101 · C
Strengths
- Prescribing clinicians are listed by name and credential rather than described as an anonymous "licensed provider network"
- A provider approves treatment before any charge is processed, and the site states plainly when it is not the right fit
- Monthly provider check-ins and a care team reachable seven days a week are included in the plan rather than sold as an upgrade
- The dose ladder is published for both molecules, so a dose escalation has a known price attached before it happens
Where it loses points
- The dispensing pharmacy is disclosed only in post-purchase paperwork, so no 503A or 503B status can be checked before you commit
- Lab work is not part of the program: it is recommended case by case, billed separately, and may be sent to your own provider
- Explicitly no health coaching or behavioral support — clinical oversight only
- Injectable compounded medication only, with no oral route and no FDA-approved brand pathway
- Cash-pay only, so nothing routes through insurance and no claim can be submitted for you
Graded #32 · B−
Strengths
- $135 sema / $199 tirz
- All 50 states
- Both molecules
Where it loses points
- Not LegitScript-verified
- Injection-only
- Monitoring detail limited
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 544 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.